Healthcare & Biotech

London – September 29, 2026 -- JOE Media Group has launched a heart-health awareness campaign built around a Viking folk character named Jordic, using erectile dysfunction (ED) as an entry point to warn men about underlying cardiovascular disease risk.

Campaign ties ED symptoms to a two-to-five-year cardiovascular warning window

The 'Listen to Jordic' campaign, created by Havas Lynx UK for JOE Media Group, launched on World Heart Day exclusively on JOE.co.uk. Medical literature cited in the campaign indicates ED can precede cardiovascular symptoms by two to five years, offering a critical window for men to seek diagnosis.

Los Angeles – – September 29, 2026 -- Congress has passed the Accelerating Access to Critical Therapies (ACT) for ALS Reauthorization Act of 2026 (H.R. 8205), sending the bipartisan bill to the President's desk just two days before the underlying program was set to expire on September 30, 2026.

Senate approval follows House passage, clearing the path for a presidential signature

The legislation cleared the U.S. House of Representatives before the Senate gave final approval, moving the bill to the President for signature. Once enacted, the law will extend core ACT for ALS programs through 2031, continuing federal support for ALS research infrastructure and expanded access to investigational therapies.

Syracuse – – September 28, 2026 -- Fuse Oncology and Associated Medical Professionals of NY (AMP), an affiliate of U.S. Urology Partners, a General Atlantic company, have launched a proof of concept for FuseRx, a clinical workflow platform for radiation oncology, at AMP's Center of Advanced Radiation Excellence in Syracuse.

Prostate cancer volume drives the test case

The American Cancer Society projects about 333,800 new U.S. prostate cancer cases in 2026, making it the most common cancer in American men after skin cancer. Roughly a third of men with localized disease receive radiation as primary treatment, a pathway that typically starts with a urologist diagnosis before crossing into separate oncology systems.

Washington – September 28, 2026 -- The U.S. Food and Drug Administration announced plans to evaluate changes to its application framework for new tobacco products, including e-cigarettes and nicotine pouches, aiming to simplify the pathway for these products to reach the market.

Truth Initiative warns weakened review could undermine public health protections

Kathy Crosby, CEO and President of Truth Initiative, said any changes that reduce the scientific evidence required or diminish the review process would compromise the FDA's regulatory role. The law currently requires the agency to assess a product's components, ingredients, toxicological profile and health impact, alongside risks and benefits to the broader population, including youth and non-users.

Oakland – – September 28, 2026 -- Blue Shield of California has pledged a $300,000 multi-year investment to Alameda County Community Food Bank (ACCFB), marking the first deployment under the nonprofit insurer's new statewide Food as Health initiative.

Blue Shield becomes the first and largest corporate sponsor of ACCFB's Food as Medicine program

The funding will expand a program that delivers medically supportive food and nutrition education to eligible Medi-Cal members managing chronic conditions. The investment strengthens infrastructure, data collection, and evaluation systems needed to scale the model beyond its current reach.

Roggwil, Switzerland – September 28, 2026 -- Honest Lasers has launched the Honest Pro, a Swiss-manufactured diode laser system combining three wavelengths and integrated contact cooling for aesthetic and medical clinics worldwide.

Three wavelengths operate within a single clinical platform

The Honest Pro integrates 755 nm, 808 nm, and 1064 nm wavelengths in one system, each targeting melanin at different tissue depths to allow practitioners to treat varied hair and skin types without switching devices. The system runs at a maximum pulse rate of 10 Hz, which Honest Lasers designed for stable fluence delivery across repeated treatments during a full clinic workday.

Albuquerque, N.M. – September 28, 2026 -- Eden Radioisotopes has secured New Mexico state economic support and locked in Kiewit Nuclear Solutions Co. as its engineering, procurement and construction partner for a planned $1.4 billion medical isotope production facility in Lea County, New Mexico.

New Mexico backs up to $1.4 billion investment through tax incentives

Economic Development New Mexico confirmed the state will support Eden's investment through the Job Training Incentive Program, high-wage and rural job tax credits, and LEDA GRT Share. The project is projected to create 205 jobs statewide and generate more than $1.5 billion in economic impact over 10 years.

Virginia Beach, Va. – September 28, 2026 -- The Howard and Georgeanna Jones Foundation for Reproductive Medicine and the American Society for Reproductive Medicine (ASRM) are offering a $100,000 grant, the Georgeanna Seegar Jones, MD, Women of the Hall Investigative Scientist Award, to fund research improving assisted reproductive technology techniques used in in vitro fertilization, including bridge funding for career scientists.

Dr. Georgeanna Seegar Jones joins nine other women in the 2026 National Women's Hall of Fame class

Dr. Jones was inducted on September 24, 2026, during the biennial ceremony run by the National Women's Hall of Fame, an organization that has honored American women since 1973.

Delray Beach, Fla. – September 28, 2026 -- The global telehealth and telemedicine market is projected to grow from USD 118.8 billion in 2026 to USD 198.9 billion by 2031, expanding at a compound annual growth rate of 10.9%, according to a new report from MarketsandMarkets. A separate figure cited in the same report puts the 2025 market at USD 106.0 billion, underscoring the sector's rapid acceleration ahead of the forecast period.

Oakland, Calif. – September 28, 2026 -- The Clorox Company has officially launched Clorox Purell ProCare, a new business-to-business health and hygiene platform formed by merging CloroxPro with GOJO, the maker of Purell, following Clorox's acquisition of GOJO earlier in 2026.

Clorox Purell ProCare unifies sales and distribution under one network

The new entity operates a unified sales and service organization alongside a network of distributors, giving professional and healthcare customers access to a combined portfolio spanning Clorox, Purell, Pine-Sol and Glad brands. The business is headquartered in Akron, Ohio, with additional offices in Pleasanton, California, and Toronto, Ontario, plus operations in Ashland, Cuyahoga Falls and Wooster, Ohio, and Alpharetta, Georgia.